Related Experiment Video
Updated: Apr 15, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Pediatric Quality of Life while Supported with a Ventricular Assist Device
Jacob R Miller1, Umar S Boston1, Deirdre J Epstein1
1Section of Pediatric Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Mo, USA.
Insights
Pediatric patients on ventricular assist devices (VADs) experience significantly lower quality of life (QoL) compared to healthy or post-transplant children. Improvements in QoL for VAD support are crucial as its use increases.
Area of Science:
- Pediatric Cardiology
- Medical Devices
- Quality of Life Research
Background:
- Ventricular assist devices (VADs) are vital for pediatric heart failure patients awaiting transplant.
- While VADs improve survival, their impact on pediatric quality of life (QoL) remains understudied.
Purpose of the Study:
- To evaluate the quality of life (QoL) in pediatric patients receiving ventricular assist device (VAD) support.
- To compare the QoL of VAD-supported pediatric patients with relevant control groups.
Main Methods:
- A prospective study administered the Pediatric Quality of Life Inventory (PedsQL) 4.0 to pediatric VAD patients and their parents.
- QoL scores were collected pre-implant (when feasible), post-operatively, and periodically until transplant or death.
- VAD patient scores were compared to healthy controls, outpatients with severe heart disease, and post-heart transplant children.
Main Results:
- Thirteen pediatric patients requiring VAD support >2 weeks completed the PedsQL.
- Patients reported significantly lower total and physical QoL scores compared to all three control groups.
- Parent proxy-reported scores were significantly lower across all categories compared to controls.
Conclusions:
- Pediatric VAD patients exhibit a substantial deficit in overall QoL compared to those with severe heart disease or post-transplant.
- Psychosocial QoL was lower than healthy controls but not significantly different from other groups.
- Enhancing QoL for pediatric patients on VAD support is essential, given the increasing duration of device utilization.
Objective:
Ventricular assist devices (VADs) have emerged as an important treatment option for bridging pediatric patients with heart failure to transplant. VADs have shown improved survival; however, the pediatric quality of life (QoL) while on VAD support is unknown. We aimed to evaluate the QoL of our pediatric patients while supported with a VAD.
Design:
In this prospective study, pediatric patients who underwent VAD placement, and their parents, were administered a generic Pediatric Quality of Life Inventory (PedsQL) 4.0 pre-VAD implant, when feasible, after the acute postoperative period, and then periodically until heart transplant or death. Their final scores while on support were compared with three previously reported groups: healthy controls, outpatients with severe heart disease, and children after heart transplant.
Results:
From January 2008 to July 2014, 13 pediatric patients required VAD support greater than 2 weeks and completed a PedsQL. The mean age at implant was 10.0 ± 4.2 years and median duration of support was 1.6 (0.5-19.7) months. Eleven (85%) patients survived to transplant with one (8%) patient remaining alive on support. The median duration of support prior to their final PedsQL was 1.4 (0.5-11.4) months. Patients self-reported significantly (P < .05) lower total and physical QoL scores when compared with all three comparison groups. Self-reported psychosocial QoL scores were significantly lower than healthy controls only. Parent proxy-reported scores were significantly lower than all three comparison groups for all three categories (P < .05).
Conclusions:
A large deficit exists in the total QoL of pediatric patients supported by a VAD compared with outpatient management of severe heart disease or postheart transplant patients; however, VAD patients do represent a group with more severe heart failure. Improvements in QoL must be made, as time spent with a VAD will likely continue to increase.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation I: Indication and Settings
Assessment of Ventilation II: Respiratory Depth and Rhythm
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement:
Mitral Stenosis IV: Nursing Management

